Optimizing Implementation of Long Acting Injectable PrEP
ConditionHIV Infections
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Minnesota
About this trial
Our goal is to optimize LAI-PrEP implementation within the context of other PrEP methods. Our strategy is flexible to allow pivot to include forthcoming PrEP dosing options should they become available
Eligibility criteria
Qualifiers
18 years of age or older,
affiliated with a participating clinic, and
be involved in prescribing or supporting PrEP care delivery.
Disqualifiers
17 years of age or younger,
not affiliated with a participating clinic, and
not involved in prescribing or supporting PrEP care delivery.
16 years of age or older, and
Trial design
Treatments tested in this trial
- Plan-Do-Study-Act
Treatment groups
20 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov